Lateral diffusion of lipids in renal cells: effects of hypoxia and reoxygenation and role of cytoskeleton.
The effects of hypoxia and reoxygenation on the lateral mobility of membrane lipids were studied in primary cultures of rat proximal tubule epithelial cells at a subconfluent stage. The lipid lateral diffusion coefficient (DL) of the fluorescent probe 1-acyl-2-(N-4-nitrobenzo-2-oxa-1,3-diazol)-aminocaproyl phosphatidylethanolamine was determined in membranes of attached cells by the technique of fluorescence redistribution after photobleaching, using confocal imaging to differentiate apical from basal surfaces. Fluidity was greater in basolateral membranes than in apical membranes [DL(apical) = 3.15 +/- 0.8 and DL (basolateral) = 6.56 +/- 1.2 x 10(-10) cm2/s]. In apical membranes, 60 min of hypoxia plus 30 min of reoxygenation increased DL to 10.04 +/- 2.1. When cells were pretreated with the antioxidants superoxide dismutase, catalase, or alpha-tocopherol, there was no clear-cut effect on the hypoxia-reoxygenation-induced increase in apical membrane DL, although t-butyl hydroperoxide treatment of cells did increase DL. Disruption of the cytoskeleton with cytochalasin D or exposure to Ca(2+)-free medium markedly increased DL. However, when cells were pretreated with phallacidin to stabilize cytoskeletal actin microfilaments, the hypoxia-reoxygenation-induced change in lipid lateral mobility was completely prevented. Thus the cytoskeleton is an important regulator of the translational motion of membrane phospholipids. Hypoxia-reoxygenation may have increased DL because of cytoskeletal dysfunction.
Paller
M S
MS
Department of Medicine, University of Minnesota, Minneapolis 55455.
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D015687:Cell Hypoxia; D015638:Cytochalasin D / Q000494:pharmacology; D003599:Cytoskeleton / Q000502:physiology*; D004058:Diffusion; D005456:Fluorescent Dyes; D007687:Kidney Tubules, Proximal / Q000166:cytology / Q000378:metabolism*; D050356:Lipid Metabolism; D010100:Oxygen / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000494:pharmacology; D010714:Phosphatidylethanolamines
D000975:Antioxidants; D005456:Fluorescent Dyes; D010456:Peptides, Cyclic; D010714:Phosphatidylethanolamines; D015638:Cytochalasin D; C017613:phallacidin; C042077:N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine; D010100:Oxygen